Noile-Immune Biotech Inc. [4893.T]
TOKYO, May 14 (Pulse News Wire) – Noile-Immune Biotech Inc. (4893.T) completed the subscription process for restricted share awards as decided by its board of directors on April 15, 2026.
Key details of the issuance include: - Payment completion date: May 14, 2026 - Type of shares: Ordinary shares - Number of shares: 97,353 - Issue price per share: ¥150 - Total issue amount: ¥14.6 million The restricted share awards were granted to three internal directors and two external directors of the company. For more detailed information, refer to the press release dated April 15, 2026, concerning the issuance of restricted share awards.
🟢 Confidence: High AI-translated content.